Soybean contains a high concentration of carbohydrates that consist mainly of non-starch polysaccharides (NSP) and oligosaccharides. The NSP can be divided into insoluble NSP (mainly cellulose) and soluble NSP (composed mainly of pectic polymers, which are partially soluble in water). Monogastric animals do not have the enzymes to hydrolyze these carbohydrates, and thus their digestion occurs by means of bacterial fermentation. The fermentation of soybean carbohydrates produces short chain fatty acids that can be used as an energy source by animals. The utilization efficiency of the carbohydrates is related to the chemical structure, the level of inclusion in the diet, species and age of the animal. In poultry, soluble NSP can increase digesta viscosity, reduce the digestibility of nutrients and depress growth performance. In growing pigs, these effects, in particular the effect on gut viscosity, are often not so obvious. However, in weaning piglets, it is reported that soy oligosaccharides and soluble NSP can cause detrimental effects on intestinal health. In monogastrics, consideration must be given to the anti-nutritive effect of the NSP on nutrient digestion and absorption on one hand, as well as the potential benefits or detriments of intestinal fermentation products to the host. This mirrors the needs for i) increasing efficiency of utilization of fibrous materials in monogastrics, and ii) the maintenance and improvement of animal health in antibiotic-free production systems, on the other hand. For example, ethanol/water extraction removes the low molecular weight carbohydrate fractions, such as the oligosaccharides and part of the soluble pectins, leaving behind the insoluble fraction of the NSP, which is devoid of anti-nutritive activities. The resultant product is a high quality soy protein concentrate. This paper presents the composition and chemical structures of carbohydrates present in soybeans and discusses their nutritive and anti-nutritive effects on digestion and absorption of nutrients in pigs and poultry.

No abstract

No abstract

No abstract

Summary Alpha‐tocopherol derived from natural source is a single stereoisomer (i.e. RRR‐α‐tocopherol), whereas synthetic α‐tocopherol consists of a mixture of eight stereoisomers, including RRR‐, RRS‐, RSR‐, RSS‐α‐tocopherol (the 2R isomers, R configuration at positions 2′ of the phytyl tail) and SRR‐, SSR‐, SRS‐ and SSS‐α‐tocopherol (the 2S isomers, S configuration at positions 2′ of the phytyl tail). R and S are assigned by the sequence‐rule procedure, i.e. the priorities of the substituents decrease in clockwise direction or anti‐clockwise direction at each chiral centre. Not all these stereoisomers are equally bio‐available, which can be explained by the differences in the rate of degradation, transportation and retention. Humans and livestock animals can only utilize the 2R forms, while the 2S forms have very low bio‐availability or basically are not bio‐available. The utilization of 2R forms differs between different animal species. For humans and livestock animals, RRR‐α‐tocopherol has the highest bio‐availability compared with other stereoisomers, while other 2R forms have lower bio‐availability compared with RRR‐α‐tocopherol. The relative bio‐availability of RRR‐ and all‐rac‐α‐tocopherol is related to animal species, ages of animals and assessment criteria. In general, recent literature studies have demonstrated that the relative bioavailability of RRR‐ and all‐rac‐α‐tocopherol is 2:1, differing from the commonly used conversion factor of 1.36:1. The latter was based on rat‐resorption‐gestation test. Most recent studies have shown that this conversion factor of 1.36:1 is not applicable to livestock animals and based on other metabolic functions. When IU is required to express vitamin E activity, new conversion factors need to be defined for livestock animals. Quantitative determination of bio‐availability of the individual α‐tocopherol stereoisomers will give a more detailed picture of the bioavailability of natural and synthetic vitamin E forms.

Bio-availability of different alpha-tocopherol forms in livestock animals is measured by the increase in plasma or tissue concentrations of alpha-tocopherol after oral administration. It is generally accepted that RRR-alpha-tocopheryl acetate (natural source vitamin E derived from vegetable oil) has a higher bio-availability compared to all-rac-alpha-tocopheryl acetate (synthetic vitamin E, i.e. alpha-tocopherol produced by chemical synthesis). However, different bio-availability ratios have been reported in the literature. The major reason for conflicting results in literature studies was the inability to separate the proportion of alpha-tocopherol originating from test materials, from the proportion of alpha-tocopherol originating from basal dietary ingredients and pre-feeding. This causes significant variability. For bio-availability determination, a baseline or control treatment is essential. The estimation of bio-availability without correction for basal vitamin E status will lead to incorrect interpretation of the results. When using proper methodologies, it is possible to correct for the impact of alpha-tocopherol intake from basal ingredients and alpha-tocopherol originating from pre-feeding, therefore yielding results reflecting the true relative bio-availability of different alpha-tocopherol substances. When reviewing literature data a critical evaluation of the method used in determination of relative bio-availability is recommended.

This study evaluated the biological discrimination of different alpha-tocopherol stereoisomers (i. e. RRR-, RRS-, RSR-, RSS- and the four 2S-alpha-tocopherols) from all-rac-alpha-tocopheryl acetate supplementation in milk replacer for rearing and veal calves respectively, in practical farming conditions. Two experiments were conducted. In experiment 1, six rearing calves were fed milk replacer supplemented with 80 mg/kg all-rac-alpha-tocopheryl acetate for a period of 9 weeks. The calves were supplied calf starter concentrate from 1 to 12 weeks. In experiment 2, six veal calves were fed milk replacer supplemented with 80 mg/kg all-rac-alpha-tocopheryl acetate for a period of 24 weeks. Blood samples were taken at the start and every 4 weeks until 12 weeks for rearing calves in experiment 1, and until slaughter (24 weeks) for veal calves in experiment 2. Liver, adipose, muscle, and brain samples were taken at slaughter of the six veal calves in experiment 2. The distribution of different alpha-tocopherol stereoisomers in feed, plasma, and tissues was analyzed. In both experiments, it was observed that RRR-alpha-tocopherol was the dominant stereoisomer in plasma and tissues. The average percentage of the RRR-alpha-tocopherol stereoisomer was 64 %, and 39 % of the total alpha-tocopherol in plasma for rearing and veal calves, respectively. The higher RRR-alpha-tocopherol stereoisomer proportion as percentage of the total alpha-tocopherol in rearing calves was related to higher dietary natural vitamin E intake. Other 2R-alpha-tocopherol stereoisomers had lower utilization efficiency than RRR-alpha-tocopherol stereoisomer. 2S-alpha-tocopherol stereoisomers were basically not utilized by calves.

Intestinal pathogen binding effects are related to mannanoligocaccharides that occur in several micro-organism species e.g. fungi and yeasts. Binding varies between species depending on their size, structure and cell wall properties. The purpose of the study was to elucidate differences in adherence potential of commercially used yeast cells and possibly determine causative elements for the observed differences. Electron microscopy and surface hydrophobicity measurements reveal that Pichia guilliermondii yeast possesses distinguished traits compared to Saccharomyces cerevisiae that may account for observed differences in pathogen binding efficiency. Pichia guilliermondii significantly inhibited adherence of pathogenic strains of Escherichia coli and Salmonella enterica in small intestinal epithelium of swine and broiler chicken. Treatment of Pichia yeast with digestive fluids significantly increased this effect. In-vivo, gastric activation occurs naturally as verified by broiler assays with P. guilliermondii. P. guilliermondii and S. cerevisiae retained their inhibitory effects on pathogenic E. coli adherence after passing through the upper digestive tract. Jejunal digesta recovered from birds treated with P. guilliermondii showed higher inhibitory effect than digesta from birds treated with the S. cerevisiae yeast. The inhibitory effect was still detectable in ileal digesta. Intact, non-gastric treated P. guilliermondii was as effective as the gastric pre-treated yeast, suggesting that digestive enzymes of broiler chicken were capable of activating yeast cells in-situ.